Moneycontrol PRO
HomeNewsBusinessMoneycontrol ResearchRallis India Q3 review: Operational environment overhang to continue, time for an overhaul

Rallis India Q3 review: Operational environment overhang to continue, time for an overhaul

Earnings were impacted due to certain one off items which were taken on account of delay in receipts on sales.

January 21, 2019 / 17:07 IST
Representative Image
     
     
    26 Aug, 2025 12:21
    Volume
    Todays L/H
    More

    Ruchi Agrawal
    Moneycontrol Research

    Highlights

    • Disappointing Q3 results, EBITDA degrowth
    • High input costs eat away profitability
    • Stretched working capital position
    • Substantial capex plans in the next 5-6 years

     -------------------------------------------------

    Rallis India reported a disappointing third quarter ended December 2018 with a substantial contraction in profits and margins despite a uptick in revenue. Overhang of high input costs ate away the profitability for yet another quarter.

    rallis1

    Key positives

    The 7 percent YoY uptick in revenue was majorly on account of price upticks especially in the international markets. Foreign exchange exposure worked in favour and had a positive impact on income.

    Earnings were impacted due to certain one off items which were taken on account of delay in receipts on sales. While provision have been made in line with the policy, the management does not recognise these as bad debts and expects to recover them in Q4FY19.

    The company is now focusing on launching more specialty products with higher margins which should help improve margins in the future.

    Rallis has started foraying into backward integration projects to ensure smooth availability of inputs and to cut off from the vagaries of supply disruptions. This could help in improving margins in the long term.

    Key negatives

    Owing to adverse conditions there was industry wide cash stress which resulted in a stretched working capital position for the company during the quarter. This led to higher working capital loans which increased the interest cost.

    The domestic markets remained on a weak footing and price upticks during the quarter were minimal. However, raw material cost continued to rise on account of the China supply issues. This led to substantial erosion of margins and profits. Rallis imports close to 45 percent of its raw materials from china.

    Volumes during the quarter remained largely flat

    Metahalix (the seed business) saw a 12 percent YoY contraction in revenue and continued to be unprofitable for another quarter.

    While the price of many chemicals has started to come off, the management does not expect significant relief in the near term.

    Crop acreages and reservoir levels are lower YoY in the current Rabi season. This could mean a continued stress on the company’s performance in Q4FY19.

    Other notes

    While the management sees API (active pharmaceutical ingredient) as an attractive segment, foray into only one molecule that too organically is somethings which is not profitable and the company might look at addressing this in the coming quarters. While there is no visibility, management indicated chances of an inorganic expansion to make the segment profitable.

    Rallis is planning a Rs 800 crore investment in the next 5-6 years for building a facility in Dahej for the manufacture of formulation, technicals and associated intermediary products for both domestic and international markets. The first Rs 100 crore phase of this investment is scheduled to be completed by March 2019 and the next Rs 173 crore phase by December 2019. The project is expected to bring about stronger backward integration

    Rallis' management has approved full integration with Metahelix – the seed business of the company with Rallis. It also plans to look out for expansion in the seed portfolio and is open to go the inorganic route.

    Outlook

    Rallis2

    The stock has corrected almost 13 percent in the last 12 months and is currently almost 42 percent below its 52 week high post which it is trading at a 2019E P/E of 17x. The management is working to foray into a more profitable product mix which would augur well for the company’s margins in the longer term. Commercialisation of new molecules would be something to look out for.

    With a renewed look on the company’s strategy and announcement of capex (which was not there since past 3-4 years), we see the group might turn around from the current mess in the long term. However, the company is currently impacted by external operating environment, and we believe the overhang would continue in the near term

     Follow @Ruchiagrawal

    For more research articles, visit our Moneycontrol Research Page.

    Ruchi Agrawal
    first published: Jan 21, 2019 05:07 pm

    Disclosure & Disclaimer

    This Research Report / Research Recommendation has been published by Moneycontrol Dot Com India Limited (hereinafter referred to as “MCD”) which is a registered Investment Advisor under the Securities and Exchange Board of India (Investment Advisers) ...Read More

    Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

    Subscribe to Tech Newsletters

    • On Saturdays

      Find the best of Al News in one place, specially curated for you every weekend.

    • Daily-Weekdays

      Stay on top of the latest tech trends and biggest startup news.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347
    CloseOutskill Genai